Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- B. Riley Securities analyst Kalpit Patel initiated coverage on ArriVent BioPharma, Inc. (NASDAQ:AVBP) with a Buy rating and announced a price target of $37. ArriVent BioPharma shares closed at $19.60 on Wednesday. See how other analysts view this stock.
- Goldman Sachs analyst Noah Poponak initiated coverage on Amentum Holdings, Inc. (NYSE:AMTM) with a Neutral rating and announced a price target of $21. Amentum Holdings shares closed at $19.03 on Wednesday. See how other analysts view this stock.
- Morgan Stanley analyst Judah Frommer initiated coverage on Celldex Therapeutics, Inc. (NASDAQ:CLDX) with an Overweight rating and announced a price target of $46. Celldex Therapeutics shares closed at $19.95 on Wednesday. See how other analysts view this stock.
- JP Morgan analyst Detlef Winckelmann initiated coverage on International Paper Company (NYSE:IP) with an Overweight rating and announced a price target of $59. International Paper shares closed at $52.62 on Wednesday. See how other analysts view this stock.
- Scotiabank analyst Patrick Colville initiated coverage on Microsoft Corporation (NASDAQ:MSFT) with a Sector Outperform rating and announced a price target of $470. Microsoft shares closed at $387.82 on Wednesday. See how other analysts view this stock.
Considering buying MSFT stock? Here’s what analysts think:
Read This Next:
Photo: Shutterstock
Market News and Data brought to you by Benzinga APIs
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
